42 U.S.C. § 1320f–7 — Limitation on administrative and judicial review
submitted 91 years ago by Pub. L. 117-169 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 130 words · no verdicts yet
The listed drug-selection, price, and renegotiation decisions cannot be reviewed administratively or judicially. The section identifies each decision covered by that bar.
There is no administrative or judicial review of: (1) the Secretary’s determination of a drug* or biological-product unit* under section 1320f(c)(6); (2) drug selection, negotiation-eligibility determinations, qualifying-single-source-drug determinations, or application of section 1320f–1(f); (3) a maximum fair price* determined under section 1320f–3(b) or (f); or (4) determinations or selections of renegotiation-eligible drugs under section 1320f–3(f)(2) and (f)(3).
There shall be no administrative or judicial review of any of the following:
The determination of a unit*, with respect to a drug* or biological product, pursuant to section 1320f(c)(6) of this title.
The selection of drugs under section 1320f–1(b) of this title, the determination of negotiation-eligible drugs under section 1320f–1(d) of this title, and 1 the determination of qualifying single source drugs under section 1320f–1(e) of this title the 2 application of section 1320f–1(f) of this title,.3
The determination of a maximum fair price* under subsection (b) or (f) of section 1320f–3 of this title.
The determination of renegotiation-eligible drugs under section 1320f–3(f)(2) of this title and the selection of renegotiation-eligible drugs under section 1320f–3(f)(3) of this title.
Source credit: (Aug. 14, 1935, ch. 531, title XI, § 1198, as added and amended Pub. L. 117–169, title I, §§ 11001(a), 11002(a)(5), Aug. 16, 2022, 136 Stat. 1851, 1861.)
- 1935Enacted · Pub. L. 117-169 · 136 Stat. 1851, 1861
A history note hasn’t been published yet. The record shows enactment by Pub. L. 117-169 on 1935-08-14.
all 0 arguments · sorted by: best
no arguments yet — make the first case